The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $68.02

Today's change+0.13 +0.19%
Updated December 7 8:00 PM -5GMT. Delayed by at least 15 minutes.
 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $68.02

Today's change+0.13 +0.19%
Updated December 7 8:00 PM -5GMT. Delayed by at least 15 minutes.

Health Care Select Sector SPDR up (U.S.)$0.13

Health Care Select Sector SPDR closed up Thursday by (U.S.)$0.13 or 0.19% to (U.S.)$68.02. Over the last five days, shares have lost 0.34% and are down 5.57% for the last year to date. This security has underperformed the S&P 500 by 13.77% during the last year.

Key company metrics

  • Open(U.S.) $67.68
  • Previous close(U.S.) $67.89
  • High(U.S.) $68.09
  • Low(U.S.) $67.29
  • Bid / Ask-- / --
  • YTD % change-5.57%
  • Volume7,586,638
  • Average volume (10-day)8,260,927
  • Average volume (1-month)13,626,133
  • Average volume (3-month)10,107,369
  • 52-week range(U.S.) $62.68 to (U.S.) $76.00
  • Beta0.94
  • Trailing P/E5.27×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.10
  • Dividend yield1.62%
  • Trailing EPS(U.S.) $12.92
Updated December 7 8:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1,414.10%

Based on its net profit margin of 1,414.10%, Health Care Select Sector SPDR is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:FinancialsIndustry:Investment Trusts

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Mar 31, 201403/31/2014Sep 30, 201309/30/2013Mar 31, 201303/31/2013
Revenue83746863
Total other revenue--------
Total revenue83746863
Gross profit--------
Total cost of revenue--------
Total operating expense7735
Selling / general / administrative7735
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income76676558
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets8761,204663833
Other--------
Income before tax9521,271728891
Income after tax9521,271728891
Income tax, total0000
Net income9521,271728891
Total adjustments to net income--------
Net income before extra. items9521,271728891
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9521,271728891
Inc. avail. to common incl. extra. items9521,271728891
Diluted net income9521,271728891
Dilution adjustment--------
Diluted weighted average shares187163140155
Diluted EPS excluding extraordinary itemsvalue per share5.107.825.195.73
Dividends per sharevalue per share0.440.470.410.41
Diluted normalized EPSvalue per share0.410.410.460.38